Trials / Conditions / Excessive Daytime Somnolence
Excessive Daytime Somnolence
5 registered clinical trials studyying Excessive Daytime Somnolence.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Valiloxybate (XW10172 MR) Efficacy and Safety Parkinson's Disease Study NCT05056194 | XWPharma | Phase 2 |
| Completed | Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administr NCT05008341 | Axsome Therapeutics, Inc. | Phase 1 |
| Completed | An Open Label Study of FT218 in Subjects With Narcolepsy NCT04451668 | Avadel | Phase 3 |
| Withdrawn | Start Times and Restful Sleep NCT04049682 | University of California, San Diego | — |
| Completed | Caffeine for Excessive Daytime Somnolence in Parkinson's Disease NCT00459420 | Ron Postuma | Phase 2 / Phase 3 |